TLR4 and Parkinson disease: Furthermore, rotenone treatment in TLR4-knockout (KO) mice resulted in less intestinal inflammation, intestinal and motor dysfunction, neuroinflammation, and neurodegeneration [123], which highlight the involvement of inflammation in the pathogenesis of PD and communication between the intestine and brain.